Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$27,000.00

Predicting medication usage for children and youth with neurodevelopmental conditions

EF 2024-25

Résumé
Attention-deficit hyperactivity disorder (ADHD), autism spectrum disorder (autism), and obsessive-compulsive disorder (OCD) are among the most common neurodevelopmental conditions (NDCs) that affect Canadian children and youth and are associated with disability and distress across many areas of life. Medication has proven to be effective at managing these conditions and improving life outcomes. Because each child has unique biological characteristics and presentation of symptoms, clinicians often rely on trial-and-error approaches to find a suitable medication - but these approaches are time-consuming and unnecessarily expose children to dangerous side effects.In my proposed research, I aim to use artificial intelligence (AI) to predict medication fit for children with NDCs using demographic and symptom profiles. To build these models, I will use medical data on over 5,000 children with NDCs drawn from The Province of Ontario Neurodevelopmental Disorders (POND) Network and the Adolescent Brain Cognitive Development (ABCD) Study. I will then validate the performance of the models using electronic records from the Psychopharmacology Program (PPP) at Holland Bloorview Kids Rehabilitation Hospital. Since NDCs differ in prevalence and symptom presentation by sex, the models may unfairly produce unsuitable recommendations for certain sex and gender groups. To mitigate this bias, I will analyze model outcomes and performance for each group separately and make necessary adjustments to create a fair model.Ultimately, this research will contribute towards developing a tool to aid clinicians in medication management for individuals with NDCs. This will in turn minimize exposure to adverse side effects and speed up the process of finding a suitable medication.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
529867
Name
Siddiqui Zeeshan M
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Predicting medication usage for children and youth with neurodevelopmental conditions
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Adhd; Artificial Intelligence; Autism; Medication; Mental Health; Neurodevelopmental Conditions; Neurodivergence; Ocd; Precision Health
Abstract
Attention-deficit hyperactivity disorder (ADHD), autism spectrum disorder (autism), and obsessive-compulsive disorder (OCD) are among the most common neurodevelopmental conditions (NDCs) that affect Canadian children and youth and are associated with disability and distress across many areas of life. Medication has proven to be effective at managing these conditions and improving life outcomes. Because each child has unique biological characteristics and presentation of symptoms, clinicians often rely on trial-and-error approaches to find a suitable medication - but these approaches are time-consuming and unnecessarily expose children to dangerous side effects.In my proposed research, I aim to use artificial intelligence (AI) to predict medication fit for children with NDCs using demographic and symptom profiles. To build these models, I will use medical data on over 5,000 children with NDCs drawn from The Province of Ontario Neurodevelopmental Disorders (POND) Network and the Adolescent Brain Cognitive Development (ABCD) Study. I will then validate the performance of the models using electronic records from the Psychopharmacology Program (PPP) at Holland Bloorview Kids Rehabilitation Hospital. Since NDCs differ in prevalence and symptom presentation by sex, the models may unfairly produce unsuitable recommendations for certain sex and gender groups. To mitigate this bias, I will analyze model outcomes and performance for each group separately and make necessary adjustments to create a fair model.Ultimately, this research will contribute towards developing a tool to aid clinicians in medication management for individuals with NDCs. This will in turn minimize exposure to adverse side effects and speed up the process of finding a suitable medication.
Competitiondate
202412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Siddiqui, Zeeshan M
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~